Market Value926,848,726
Total Holdings55
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARVN / Arvinas, Inc.
RVMD / Revolution Medicines, Inc.
CYBN / Cybin Inc.
SRPT / Sarepta Therapeutics, Inc. Call
SRPT / Sarepta Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Call
NXTC / NextCure, Inc.
ENGN / enGene Holdings Inc.
SYRE / Spyre Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
ATXS / Astria Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
ANNX / Annexon, Inc. Call
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ELEV / Elevation Oncology, Inc.
NMRA / Neumora Therapeutics, Inc.
IOBT / IO Biotech, Inc.
IRON / Disc Medicine, Inc.
AVTX / Avalo Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
ADVM / Adverum Biotechnologies, Inc.
CLDX / Celldex Therapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BOLD / Boundless Bio, Inc.
ELVN / Enliven Therapeutics, Inc.
SKYE / Skye Bioscience, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
COGT / Cogent Biosciences, Inc.
CYTK / Cytokinetics, Incorporated
FULC / Fulcrum Therapeutics, Inc. Call
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
RAPP / Rapport Therapeutics, Inc.
ERAS / Erasca, Inc.
ALLK / Allakos Inc.
NUVL / Nuvalent, Inc.
ORKA / Oruka Therapeutics, Inc.
TRVI / Trevi Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
UNCY / Unicycive Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
ARTV / Artiva Biotherapeutics, Inc.
MRUS / Merus N.V.
VERA / Vera Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
AKRO / Akero Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
OCUL / Ocular Therapeutix, Inc.
ANNX / Annexon, Inc.
JANX / Janux Therapeutics, Inc.
IMVT / Immunovant, Inc.
IDYA / IDEAYA Biosciences, Inc.
RNAC / Cartesian Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
BEAM / Beam Therapeutics Inc.
ATYR / aTyr Pharma, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)